Literature DB >> 2482498

Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.

G P Rodgers1, G J Dover, C T Noguchi, A N Schechter, A W Nienhuis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2482498

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  4 in total

Review 1.  Transcriptional mechanisms underlying hemoglobin synthesis.

Authors:  Koichi R Katsumura; Andrew W DeVilbiss; Nathaniel J Pope; Kirby D Johnson; Emery H Bresnick
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

2.  Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.

Authors:  Jane A Little; Vicki R McGowan; Gregory J Kato; Kristine S Partovi; Jordan J Feld; Irina Maric; Sabrina Martyr; James G Taylor; Roberto F Machado; Theo Heller; Oswaldo Castro; Mark T Gladwin
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

Review 3.  Microfluidic methods to advance mechanistic understanding and translational research in sickle cell disease.

Authors:  Melissa Azul; Eudorah F Vital; Wilbur A Lam; David K Wood; Joan D Beckman
Journal:  Transl Res       Date:  2022-03-27       Impact factor: 10.171

4.  Glycosylation inhibitors efficiently inhibit P-selectin-mediated cell adhesion to endothelial cells.

Authors:  Pushpankur Ghoshal; Mythilypriya Rajendran; Nadine Odo; Tohru Ikuta
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.